Evaluation Of In-Vivo Hepato-Protective Activity of Polyherbal Extract Against Chemically Induced-Hepatotoxic Rats

Chemically induced hepatotoxicity in rats, also known as drug-induced liver injury (DILI), is a widely used model for studying liver damage caused by various chemicals and drugs. Researchers use this model to understand the mechanisms of hepatotoxicity, develop new therapies, and assess the safety of new drugs before they are tested in humans. Commonly used hepatotoxins in rats include Carbon Tetrachloride (CCl4), Thioacetamide (TAA), Paracetamol (Acetaminophen), D-Galactosamine, and Dimethyl nitrosamine (DMN). Histopathological and biochemical parameters are assessed through examination of liver tissue under a microscope and measurement of liver enzymes and markers in blood samples. The study aims to assess the in-vivo hepato-protective activity of a polyherbal extract against chemically induced-hepatotoxic rats. The objectives include conducting a literature survey, selecting plant material, procuring and authenticating it, preparing a poly-herbal combination, evaluating liver injury caused by hepatotoxic substances, investigating the test compound's ability to protect the liver against hepatotoxicity, comparing its efficacy with known hepato-protectants, and evaluating the safety profile of the test compound or herbal extract in hepatotoxic rats. In Present study, we can conclude that, This formulation preserves the activity of serum marker enzymes, which aids in the healing of hepatic tissue. At the oral dosages examined, the formulation was well tolerated and showed no symptoms of hepato-, reno-, or hematotoxicity, nor any indication of clinical toxicity. These results are confirmed by the findings of our study which is further supported by the histopathological findings. By acute and general toxicities following oral ingestion, we were able to prove that, it is a non-toxic hepatoprotective medication. This Polyherbal extract containing different types of the extract can be a best alternative for treatment of hepatotoxicity.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-22
DOI
https://doi.org/10.5281/zenodo.15490469
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation Of In-Vivo Hepato-Protective Activity of Polyherbal Extract Against Chemically Induced-Hepatotoxic Rats

Zenodo (CERN European Organization for Nuclear Research)
Drug-Induced Hepatotoxicity and Protection
article

Evaluation Of In-Vivo Hepato-Protective Activity of Polyherbal Extract Against Chemically Induced-Hepatotoxic Rats

article en

Abstract

Chemically induced hepatotoxicity in rats, also known as drug-induced liver injury (DILI), is a widely used model for studying liver damage caused by various chemicals and drugs. Researchers use this model to understand the mechanisms of hepatotoxicity, develop new therapies, and assess the safety of new drugs before they are tested in humans. Commonly used hepatotoxins in rats include Carbon Tetrachloride (CCl4), Thioacetamide (TAA), Paracetamol (Acetaminophen), D-Galactosamine, and Dimethyl nitrosamine (DMN). Histopathological and biochemical parameters are assessed through examination of liver tissue under a microscope and measurement of liver enzymes and markers in blood samples. The study aims to assess the in-vivo hepato-protective activity of a polyherbal extract against chemically induced-hepatotoxic rats. The objectives include conducting a literature survey, selecting plant material, procuring and authenticating it, preparing a poly-herbal combination, evaluating liver injury caused by hepatotoxic substances, investigating the test compound's ability to protect the liver against hepatotoxicity, comparing its efficacy with known hepato-protectants, and evaluating the safety profile of the test compound or herbal extract in hepatotoxic rats. In Present study, we can conclude that, This formulation preserves the activity of serum marker enzymes, which aids in the healing of hepatic tissue. At the oral dosages examined, the formulation was well tolerated and showed no symptoms of hepato-, reno-, or hematotoxicity, nor any indication of clinical toxicity. These results are confirmed by the findings of our study which is further supported by the histopathological findings. By acute and general toxicities following oral ingestion, we were able to prove that, it is a non-toxic hepatoprotective medication. This Polyherbal extract containing different types of the extract can be a best alternative for treatment of hepatotoxicity.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 48%
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluation Of In-Vivo Hepato-Protective Activity of Polyherbal Extract Against Chemically Induced-Hepatotoxic Rats · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS